136 related articles for article (PubMed ID: 10383529)
1. Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis.
Geus WP; Eddes EH; Gielkens HA; Gan KH; Lamers CB; Masclee AA
Aliment Pharmacol Ther; 1999 Jul; 13(7):937-43. PubMed ID: 10383529
[TBL] [Abstract][Full Text] [Related]
2. Postprandial gastric function in pancreatic insufficiency.
Regan PT; Malagelada JR; Dimagno EP; Go VL
Gut; 1979 Mar; 20(3):249-54. PubMed ID: 35448
[TBL] [Abstract][Full Text] [Related]
3. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
Gielkens HA; Eddes EH; Vecht J; van Oostayen JA; Lamers CB; Masclee AA
J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
[TBL] [Abstract][Full Text] [Related]
4. Relationship of basal and postprandial intraduodenal bile acid concentrations and plasma cholecystokinin levels with abdominal pain in patients with chronic pancreatitis.
Garcés MC; Gómez-Cerezo J; Alba D; Codoceo R; Vázquez-Muñoz E; Arnalich F; Barbado FJ; Vázquez JJ
Pancreas; 1998 Nov; 17(4):397-401. PubMed ID: 9821182
[TBL] [Abstract][Full Text] [Related]
5. [Interdigestive and postprandial duodenal pH in healthy probands, in patients with ulcer and in chronic pancreatitis].
Gerber B; Gerber S; Arendt R
Dtsch Z Verdau Stoffwechselkr; 1987; 47(4):158-64. PubMed ID: 2830092
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal gastric pH in chronic pancreatitis.
Bovo P; Cataudella G; Di Francesco V; Vaona B; Filippini M; Marcori M; Montesi G; Rigo L; Frulloni L; Brunori MP
Gut; 1995 Feb; 36(2):294-8. PubMed ID: 7883232
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
8. Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis.
Talamini G
JOP; 2005 Mar; 6(2):122-7. PubMed ID: 15767727
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
[TBL] [Abstract][Full Text] [Related]
10. Effect of intragastric or intraduodenal administration of a polymeric diet on gallbladder motility, small-bowel transit time, and hormone release.
Ledeboer M; Masclee AA; Biemond I; Lamers CB
Am J Gastroenterol; 1998 Nov; 93(11):2089-96. PubMed ID: 9820378
[TBL] [Abstract][Full Text] [Related]
11. Deficient gastric lipase secretion in pancreatic insufficiency.
Wøjdemann M; Olsen O; Larsen S; Sternby B; Rehfeld JF
Scand J Gastroenterol; 1997 Mar; 32(3):268-72. PubMed ID: 9085465
[TBL] [Abstract][Full Text] [Related]
12. Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.
Gan KH; Geus WP; Lamers CB; Heijerman HG
Dig Dis Sci; 1997 Nov; 42(11):2304-9. PubMed ID: 9398810
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
Konturek JW; Konturek SJ; Domschke W
Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.
Konturek JW; Gillessen A; Konturek SJ; Domschke W
Gut; 1995 Oct; 37(4):482-7. PubMed ID: 7489932
[TBL] [Abstract][Full Text] [Related]
15. Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency.
Jansen JB; Jebbink MC; Mulders HJ; Lamers CB
Regul Pept; 1989; 25(3):333-42. PubMed ID: 2772268
[TBL] [Abstract][Full Text] [Related]
16. Plasma cholecystokinin and somatostatin levels in chronic pancreatitis patients.
al-Eryani S; Duris I; Payer J; Huorka M; Kratochvílová H; Ondrejka P
Hepatogastroenterology; 2000; 47(33):869-74. PubMed ID: 10919050
[TBL] [Abstract][Full Text] [Related]
17. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.
Konturek JW; Bielański W; Konturek SJ; Domschke W
J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization.
Andersen JR; Bendtsen F; Ovesen L; Pedersen NT; Rune SJ; Tage-Jensen U
Int J Pancreatol; 1990 Jun; 6(4):263-70. PubMed ID: 2212745
[TBL] [Abstract][Full Text] [Related]
19. Duodenal acidification releases cholecystokinin.
Chen YF; Chey WY; Chang TM; Lee KY
Am J Physiol; 1985 Jul; 249(1 Pt 1):G29-33. PubMed ID: 4014465
[TBL] [Abstract][Full Text] [Related]
20. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
